Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

ClinicalTrials.gov ID: NCT00438867

Public ClinicalTrials.gov record NCT00438867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Female Patients With Stable Angina Pectoris Who Are Not Candidates for Revascularization

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether a one-time intracoronary infusion of Ad5FGF-4 is effective in reducing the time to onset myocardial ischemia as measured by exercise treadmill testing and improving myocardial blood flow as measured by SPECT imaging. Exercise capacity, angina functional class, patient symptoms and quality of life will also be evaluated to characterize the efficacy of Ad5FGF-4. Short-term and long-term safety of Ad5FGF-4 will also be evaluated.

Study identification

NCT ID
NCT00438867
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cardium Therapeutics
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Genetic

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2007 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Not listed
Last update posted
Feb 13, 2013

Started 2007

United States locations

U.S. sites
47
U.S. states
30
U.S. cities
47
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294 —
Banner Heart Hospital Phoenix Arizona 85206 —
Southwest Heart Tucson Arizona 85715 —
Access Clinical Trials Beverly Hills California 90210 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Mission Internal Medical Group Mission Viejo California 92691 —
UCSD Medical Center San Diego California 92103 —
Aurora Denver Cardiology Aurora Colorado 80012 —
South Denver Cardiology Littleton Colorado 80120 —
Cardiovascular Research Institute Washington D.C. District of Columbia 20010 —
University of Florida Gainesville Florida 32610 —
Florida Hospital Orlando Florida 32803 —
St Joseph's Research Institute Atlanta Georgia 30342 —
St. Luke's Idaho Cardiology Associates Boise Idaho 83712 —
Fox Valley Cardiovascular Consultants Aurora Illinois 60504 —
Midwest Heart Foundation Lombard Illinois 60148 —
Northern Indiana Research Alliance Fort Wayne Indiana 46804 —
The Care Group Indianapolis Indiana 46290 —
Cardiovascular Associates Louisville Kentucky 40205 —
Maine Medical Center Portland Maine 04102 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Michigan Medical Center Ann Arbor Michigan 48109 —
William Beaumont Hospital Royal Oak Michigan 48073 —
St. Mary's Duluth Clinic Duluth Minnesota 55805 —
Minneapolis Heart Institute Minneapolis Minnesota 55407 —
Mid America Heart Institute Kansas City Missouri 64111 —
St. Anthony's Medical Center St Louis Missouri 63128 —
BryanLGH Heart Institute Lincoln Nebraska 68506 —
Creighton University Omaha Nebraska 68131 —
The Valley Hospital Ridgewood New Jersey 07450 —
Lenox Hill Heart & Vascular Institute New York New York 10021 —
Duke University Medical Center Durham North Carolina 27710 —
The Lindner Clinical Trial Center Cincinnati Ohio 45219 —
North Ohio Heart Center Elyria Ohio 44035 —
Oklahoma Cardiovascular Associates Oklahoma City Oklahoma 73109 —
Providence Heart & Vascular Institute Portland Oregon 97225 —
Heritage Cardiology Associates Camp Hill Pennsylvania 17011 —
Geisinger Clinic Danville Pennsylvania 17822 —
The Miriam Hospital Providence Rhode Island 02906 —
The Stern Cardiovascular Center Germantown Tennessee 38138 —
Meharry Medical College Nashville Tennessee 37208 —
Baylor University Medical Center at Dallas Dallas Texas 75226 —
South Texas Cardiovascular Consultants San Antonio Texas 78229 —
Cardiovascular Associates of East Texas Tyler Texas 75701 —
Fletcher Allen Health Care Burlington Vermont 05401 —
Swedish Medical Center Seattle Washington 98122 —
Care Foundation Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00438867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00438867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →